Quantcast

Latest Neuroprotection Stories

2008-09-09 21:00:07

German scientists say a protein hormone used to increase blood production in medical treatments and boost athletic performance might also improve memory. Max Planck Institute researchers say the memory-enhancing effects of erythropoietin, known as EPO, aren't related to its effects on blood production but are due to direct influences on neurons in the brain. The researchers, led by Hannelore Ehrenreich, said their findings might prove useful in the treatment of diseases affecting brain...

2008-09-05 06:00:23

Neurologix, a biotechnology company engaged in the development of gene therapies for the brain and central nervous system, and Aegera Therapeutics, a private clinical stage company focused on oncology and neuropathic pain, have executed an exclusive license agreement. Pursuant to the agreement, Neurologix has exclusively licensed the worldwide rights, excluding China, for the use of the x-linked inhibitor of apoptosis protein (XIAP) gene for therapeutic or prophylactic purposes in the...

2008-08-21 09:01:14

Biovail Corporation has appointed Neil Sussman as vice president of neurologic and psychiatric development of Biovail Technologies. Dr Sussman brings a wealth of business and academic experience in the field of neurology and other central nervous system (CNS) disorders to Biovail. Prior to joining Biovail, Dr Sussman was president of NMSNeuro Consulting, specializing in therapeutic areas such as dementia, mania, neuroprotection, multiple sclerosis and Parkinson's disease. Before that, Dr...

2008-08-20 09:01:30

Biovail Corporation (NYSE:BVF)(TSX:BVF) today announced the appointment of Dr. Neil M. Sussman as Vice-President, Neurologic and Psychiatric Development of Biovail Technologies, Ltd. The appointment is effective immediately. Dr. Sussman brings a wealth of business and academic experience in the field of neurology and other central nervous system (CNS) disorders to Biovail. "We are delighted to have an individual as qualified as Dr. Sussman join our Medical and Scientific Affairs team,"...

2008-07-30 15:01:17

CHICAGO, July 30 /PRNewswire-FirstCall/ -- ANAVEX Life Sciences Corp. (OTCBB: AVXL), a biopharmaceutical company engaged in the discovery and development of novel therapeutics to treat Central Nervous System (CNS) diseases and cancer, today presented data from the company's novel compound, ANAVEX 1-41, targeting Alzheimer's disease, at the International Conference on Alzheimer's Disease (ICAD) 2008, Chicago, USA, July 26 to 31, 2008. The compound has a synergistic neuroprotective and...

2008-06-29 06:01:42

By Mercier, Marie Le Mathieu, Veronique; Haibe-Kains, Benjamin; Bontempi, Gianluca; Mijatovic, Tatjana; Decaestecker, Christine; Kiss, Robert; Lefranc, Florence Abstract Galectin (Gal) 1 is a hypoxia-regulated proangiogenic factor that also directly participates in glioblastoma cell migration. To determine how Gal-1 exerts its proangiogenic effects, we investigated Gal-1 signaling in the human Hs683 glioblastoma cell line. Galectin 1 signals through the endoplasmic reticulum transmembrane...

2008-06-27 21:02:30

U.S. researchers say they have slowed the progress of Amyotrophic Lateral Sclerosis, or Lou Gehrig's disease in mice, using cells from umbilical cord blood. In ALS, motor neurons in the spinal cord and brain degenerate, causing progressive muscle weakness, paralysis and, finally, respiratory failure three to five years after diagnosis. University of South Florida in Tampa researchers say mononuclear human umbilical cord blood -- MNC hUCB -- cells may modulate immune and inflammatory...

2008-06-24 15:01:08

ATHENS, GREECE, June 24 /PRNewswire-FirstCall/ -- Anavex Life Sciences Corp. ("ANAVEX") (OTCBB: AVXL) announces its participation at the International Conference on Alzheimer's Disease 2008 (July 26-31, 2008, Chicago, USA), where it will present results obtained with ANAVEX 1-41 demonstrating a protective effect against the neurotoxicity of amyloid (beta)25-35 peptide (A(beta)25-35) in mice. This peptide is used to mimic the neurodegenerative processes found in Alzheimer's disease (AD) and...

2006-04-05 14:30:00

By Karla Gale SAN DIEGO - Daily testosterone treatment of men with relapsing remitting multiple sclerosis (MS) -- the most common form of the disease in which symptoms wax and wane -- appears to be neuroprotective while improving their brain function. That's according to research presented this week at the American Academy of Neurology 58th Annual Meeting here. "Men are less likely to get MS, and they tend to be older when they do," presenter Dr. Nancy Sicotte told Reuters Health. "So our...

2005-06-28 16:37:05

St. Louis, June 28, 2005 -- Expectant mothers at risk of premature birth may want to consider drinking pomegranate juice to help their babies resist brain injuries from low oxygen and reduced blood flow, a new mouse study from Washington University School of Medicine in St. Louis suggests. In humans, decreased blood flow and oxygen to the infant brain is linked to premature birth and other irregularities during pregnancy, birth and early development. The phenomenon, which is called hypoxia...


Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.